1-naphthylisothiocyanate has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Gao, Q; He, W; Li, G; Liu, D; Shang, T; Wang, C; Xiang, D; Xu, Y; Zhang, C; Zu, Y | 1 |
1 other study(ies) available for 1-naphthylisothiocyanate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Ginsenoside Rg1 alleviates ANIT-induced cholestatic liver injury by inhibiting hepatic inflammation and oxidative stress via SIRT1 activation.
Topics: 1-Naphthylisothiocyanate; Animals; Cholestasis; Diabetes Mellitus, Type 2; Ginsenosides; Inflammation; Liver; Mice; Molecular Docking Simulation; Oxidative Stress; Panax; Saponins; Sirtuin 1 | 2024 |